Articles: chronic.
-
Symptoms of Respiratory Disease PostersSESSION TYPE: Poster PresentationsPRESENTED ON: Saturday, March 22, 2014 at 01:15 PM - 02:15 PMPURPOSE: FeNO (fractional exhaled nitric oxide) may help identify cases of NAEB (nonasthmatic eosinophilic bronchitis) or asthma. The aim of this study is to evaluate the utility of FeNO in the evaluation of chronic cough ⋯ The following authors have nothing to disclose: Vijo PouloseNo Product/Research Disclosure Information.
-
COPD Comorbidity PostersSESSION TYPE: Poster PresentationsPRESENTED ON: Saturday, March 22, 2014 at 01:15 PM - 02:15 PMPURPOSE: Comorbidities with COPD (Chronic Obstructive Pulmonary Disease) is one of the most important problems. Previous reports suggested that systemic inflammation may be the link between COPD and comorbidities, but this issue is still low debated in Japan. Whatever the mechanism of comorbidities may be, it has important clinical, prognostic and therapeutic problems. In this study, investigated for the evaluation and measures about COPD burden patients of the current situation in rural area Japan. And also aimed that through comorbidities, contributes to improving patients care and COPD awareness. ⋯ The following authors have nothing to disclose: Tomoyasu UnoNo Product/Research Disclosure Information.
-
Comorbidities of OSA PostersSESSION TYPE: Poster PresentationsPRESENTED ON: Saturday, March 22, 2014 at 01:15 PM - 02:15 PMPURPOSE: To provide new insight into the expression of TLR2 and TLR4 from OSAHS. ⋯ The following authors have nothing to disclose: Junjun HuangNo Product/Research Disclosure Information.
-
Slide PresentationsPRESENTED ON: Sunday, March 23, 2014 at 04:15 PM - 05:15 PMPURPOSE: The purpose of this study was to evaluated the effect of triple-combined long acting inhaled bronchodilator treatment with roflumilast and dual-combined long acting inhaled bronchodilator and single-long acting inhaled bronchodilator treatment on exacerbations in patients with severe and very severe chronic obstructive pulmonary disease(COPD). ⋯ The following authors have nothing to disclose: Alizamin Sadigov, Sakhavatdin Akhundov, Rovshan BagirovNo Product/Research Disclosure Information.
-
Infectious Disease Case Report Posters ISESSION TYPE: Case Report PosterPRESENTED ON: Sunday, March 23, 2014 at 01:15 PM - 02:15 PMINTRODUCTION: Introduction- 65 y o M with preexisting CHF, with Ejection fraction 30%, COPD on medicines ramipril - 2.5 mg/d, eplerenone - 25 mg, aspirin and clopidogrel 75 mg, cardace- 6.25 mg, atorvastatin - 10 mg, isosorbide mononitrate 20 mg and Lasix 40 mg. ⋯ The following authors have nothing to disclose: Nabaneeta KhattarNo Product/Research Disclosure Information.